中南部早期乳腺癌治疗差异:有什么变化吗?
Ambria S Moten1, Payton Grande2, Ashley Hendrix1
1Department of Surgery, The University of Tennessee Health Science Center, Memphis, TN, USA.
American journal of surgery
|July 12, 2023
概括
在中南部,乳腺癌治疗的种族差异仍然存在. 黑人患者接受的手术和激素治疗较少,但某些治疗方法的死亡风险较低.
科学领域:
- 在瘤学瘤学.
- 健康差异 在健康上的差异
- 流行病学 流行病学
背景情况:
- 癌症治疗中的种族差异是一个重大的公共卫生问题.
- 了解这些差异对于改善患者治疗结果至关重要.
研究的目的:
- 调查乳腺癌治疗和生存的持续种族差异.
- 分析中南部地区按种族的治疗模式和死亡风险.
主要方法:
- 从中南部医疗保健系统瘤登记处对早期乳腺癌患者的回顾性分析.
- 回归分析以评估种族,接受治疗和死亡率之间的关联.
主要成果:
- 与白人患者相比,黑人患者 (38.8%) 接受手术和激素治疗的可能性较低.
- 黑人患者更有可能接受放射和化疗.
- 在黑人患者中,乳房切除和激素治疗与较低的死亡风险有关.
结论:
- 在中南部,乳腺癌治疗和生存率的种族差异仍然存在.
- 需要进一步改进治疗策略,以优化所有乳腺癌患者的生存率.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Survival Analysis
394
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
394


